glp-1 drug market size North America Glucagon-Like Peptide-1 (GLP-1) Agonist GLP-1 Diabetes Treatment Drugs Market

glp-1 drug market size

glp-1 drug market size North America Glucagon-Like Peptide-1 (GLP-1) Agonist GLP-1 Diabetes Treatment Drugs Market

Name: glp-1 drug market size North America Glucagon-Like Peptide-1 (GLP-1) Agonist GLP-1 Diabetes Treatment Drugs Market
Brand: neboallen.info
SKU: 64615579008
Price: 27.53 USD
Availability: InStock
Rating: 4.5481 (14 reviews)

SKU: 64615579008

4.5

EUR27.53 EUR72.53

Pay in 4 interest-free payments of $6.88 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

primarily involving a medical condition known as gastroparesis, or stomach paralysis

Monitoring Side Effects Most side effects occur during the dose-escalation phase and are usually temporary

Generation of knockout, knockdown and cDNA overexpression cell lines sgRNAs (oligonucleotide sequences are indicated below) were cloned into lentiCRISPR-v2 (Addgene) (for GCLC )or into lentiCRISPR-v1 (Addgene) (for SLC25A39 ) linearized with BsmBI by T4 ligase (NEB)